Quantum BioPharma Ltd. (CSE:QNTM)
Canada · Delayed Price · Currency is CAD 5.18
-0.18 (-3.36%)
Jun 15, 2026, 1:32 PM EST
Quantum BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -31.16 | -26.18 | -14.2 | -17.9 | -23.61 | -35.29 |
Depreciation & Amortization | 0.54 | 0.55 | 0.49 | 2.51 | 4.53 | 4.05 |
Other Amortization | 1.49 | 1.49 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.12 | 0.12 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | 4.56 | - | - |
Loss (Gain) From Sale of Investments | -0.2 | -0.43 | 0 | 0.38 | 0.23 | 0.86 |
Stock-Based Compensation | 3.55 | 2.95 | 0.15 | 3.84 | 1.53 | 7.44 |
Other Operating Activities | 21.61 | 11.29 | -3.08 | -5.84 | -2.76 | 0.68 |
Change in Accounts Receivable | 0.12 | 0.2 | -0.15 | 0.16 | 0.22 | -0.11 |
Change in Inventory | 0.04 | 0.07 | -0.12 | - | - | - |
Change in Accounts Payable | -1.91 | 1.18 | 4.27 | 2.05 | -0.7 | 3.6 |
Change in Unearned Revenue | -1 | -1 | 1 | - | - | - |
Change in Other Net Operating Assets | 1.14 | 1.54 | 4.75 | -0.57 | -6.64 | -0.61 |
Operating Cash Flow | -5.64 | -8.24 | -6.88 | -10.83 | -28.33 | -20.75 |
Capital Expenditures | - | - | - | - | -0.11 | - |
Cash Acquisitions | - | - | - | 0.03 | - | 0.77 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.25 | -0.5 |
Investment in Securities | -0 | 1.18 | -0.5 | -0.74 | -0.24 | - |
Other Investing Activities | -3.49 | -3.13 | -1 | 0.44 | 12.73 | - |
Investing Cash Flow | -3.5 | -1.95 | -1.5 | -0.27 | 12.12 | 0.27 |
Short-Term Debt Issued | - | 2.11 | 0.31 | - | - | - |
Long-Term Debt Issued | - | 3.24 | 0.7 | - | - | - |
Total Debt Issued | 4.98 | 5.36 | 1.01 | - | - | - |
Short-Term Debt Repaid | - | -1.5 | - | - | - | -0.07 |
Long-Term Debt Repaid | - | -0.11 | -0.06 | -0.19 | -0.14 | -0.06 |
Total Debt Repaid | -2.61 | -1.61 | -0.06 | -0.19 | -0.14 | -0.13 |
Net Debt Issued (Repaid) | 2.37 | 3.75 | 0.95 | -0.19 | -0.14 | -0.13 |
Issuance of Common Stock | 5.88 | 0.53 | 10.67 | 0.02 | - | 38.34 |
Repurchase of Common Stock | - | - | - | -2.96 | -1.93 | - |
Other Financing Activities | 1.72 | 1.82 | - | - | - | - |
Financing Cash Flow | 9.96 | 6.1 | 11.62 | -3.13 | -2.07 | 38.21 |
Net Cash Flow | 0.82 | -4.09 | 3.24 | -14.22 | -18.28 | 17.73 |
Free Cash Flow | -5.64 | -8.24 | -6.88 | -10.83 | -28.45 | -20.75 |
Free Cash Flow Per Share | -1.49 | -2.51 | -6.05 | -17.78 | -47.74 | -38.59 |
Levered Free Cash Flow | 2.16 | -6.83 | -5.13 | -15.51 | -2.75 | -8.19 |
Unlevered Free Cash Flow | 1.8 | -7 | -5.1 | -15.51 | -2.72 | -8.15 |
Change in Working Capital | -1.6 | 1.99 | 9.76 | 1.64 | -7.12 | 2.89 |